NRC HEALTH
For the period ended Oct 27, 2026. Filed Oct 27, 2026.
View on SEC.govAbout this filing
A notice of a major event between regular reports, such as results, a deal or a change of executives. It is often the first formal record of the news.
Oct 27, 2026 · Filed Oct 27, 2026
Use the contents to explore the available documents and sections.
NRC$25.86+1.5%Stored close · as of Nov 6, 2026
Contents
EX-99.1 · Adjusted EBITDA and Adjusted EBITDA Margin
Adjusted EBITDA and Adjusted EBITDA Margin
| · · Three months endedSeptember 30, · · · Nine months endedSeptember 30, · | ||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| · · 2026 · · · 2025 · · · 2026 · · · 2025 · | ||||||||||||||||
| Net income | | $4,704 | | | $4,122 | | | $4,643 | | | $9,802 | | ||||
| Add back: | | | | | | | | | | | | | | | | |
| Depreciation and amortization | | | 2,068 | | | | 2,195 | | | | 6,358 | | | | 5,479 | |
| Interest expense | | | 1,532 | | | | 1,461 | | | | 4,108 | | | | 3,393 | |
| Income taxes | | | 2,698 | | | | 2,151 | | | | 2,601 | | | | 4,774 | |
| Management transition costs1 | | | - | | | | - | | | | 3,160 | | | | 6,640 | |
| Non-cash stock compensation expense (benefit) | | | (134) | | | 925 | | | | 8,844 | | | | 1,403 | | |
| Adjusted EBITDA | | $10,868 | | | $10,854 | | | $29,714 | | | $31,491 | | ||||
| | | | | | | | | | | | | | | | | |
| Net income margin | | | 12% | | | 12% | | | 4% | | | 10% | ||||
| Adjusted EBITDA margin | | | 28% | | | 31% | | | 27% | | | 31% | ||||
| 1) | See 'Non-GAAP Financial Measures' above for a description of the composition of management transition costs and the change from prior period presentation. |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.